ArticleBiochemical genetics2022

miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway.

Zhe-Long Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.